Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-06 Sale |
2023-02-08 4:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $26.83 | $1,417,909 | 17,836 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:59 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
69 | $28.43 | $1,962 | 90,069 (Direct) |
View |
| 2023-01-12 Sale |
2023-01-13 4:44 pm |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
39,000 | $26.84 | $1,046,782 | 32,000 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 5:01 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $25.04 | $626,025 | 265 (Direct) |
View |
| 2022-10-06 Sale |
2022-10-07 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
29,899 | $25.9 | $774,411 | 32,000 (Direct) |
View |
| 2022-10-06 Sale |
2022-10-07 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
16,231 | $25.29 | $410,508 | 17,659 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 5:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
33,769 | $25.02 | $844,890 | 17,659 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 5:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
4,101 | $25.06 | $102,777 | 32,000 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 4:18 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $23.11 | $4,020,056 | 17,836 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 5:34 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
279,420 | $23.64 | $6,604,327 | 17,836 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-16 5:34 pm |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
78,815 | $24.08 | $1,897,988 | 75,763 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 4:14 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $25.04 | $625,893 | 530 (Direct) |
View |
| 2022-08-05 Sale |
2022-08-09 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
24,000 | $23.02 | $552,382 | 32,000 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 6:42 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
31,602 | $21.06 | $665,393 | 17,659 (Direct) |
View |
| 2022-07-06 Sale |
2022-07-08 5:51 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
15,109 | $21.07 | $318,407 | 17,659 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-05 4:09 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $19 | $1,183,430 | 17,836 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
104,173 | $17.48 | $1,820,735 | 17,836 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 5:32 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
1,412 | $16.65 | $23,510 | 81,412 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 5:31 pm |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
968 | $16.65 | $16,117 | 30,968 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $6.38 | 17,836 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $0 | 17,836 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:02 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
410,000 | $28.55 | 410,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:02 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
32,000 | $28.55 | 32,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:01 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Madigan Catherine Chief Medical Officer |
110,000 | $28.55 | 110,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:00 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
110,000 | $28.55 | 110,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:59 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
90,000 | $28.55 | 90,069 (Direct) |
View |
| 2023-01-31 Other |
2023-02-03 4:59 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
69 | $17.32 | 90,069 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:58 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
17,000 | $28.55 | 17,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:57 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
32,000 | $0 | 107,763 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:56 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
16,000 | $0 | 32,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:55 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
16,000 | $0 | 48,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:54 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
16,000 | $0 | 48,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:52 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
16,000 | $0 | 48,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:52 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director |
16,000 | $0 | 48,000 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:44 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
24,000 | $9.47 | 32,000 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-13 4:44 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
15,000 | $13.58 | 32,000 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:44 pm |
N/A 2030-02-12 |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
39,000 | $0 | 32,000 (Direct) |
View |
| 2022-12-05 Option Award |
2022-12-05 4:41 pm |
N/A 2032-12-05 |
Syndax Pharmaceuticals Inc | SNDX | Sabus Steve M Chief Commercial Officer |
220,000 | $25.44 | 220,000 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:01 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
3,772 | $6.35 | 265 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:01 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
21,228 | $6.38 | 265 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:01 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $0 | 265 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
20,782 | $7.88 | 32,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
9,117 | $8.93 | 32,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A 2028-05-23 |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
29,899 | $0 | 32,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
16,231 | $8.77 | 17,659 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
16,231 | $0 | 17,659 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
33,769 | $8.77 | 17,659 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
33,769 | $0 | 17,659 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
3,218 | $7.88 | 32,000 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
883 | $8.93 | 32,000 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A 2028-05-23 |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
4,101 | $0 | 32,000 (Direct) |
View |
| 2022-09-19 Exercise |
2022-09-21 4:18 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $10.9 | 17,836 (Direct) |
View |
| 2022-09-19 Exercise |
2022-09-21 4:18 pm |
N/A 2025-09-09 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
173,988 | $0 | 17,836 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
226,386 | $7.2 | 17,836 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
53,034 | $10.9 | 17,836 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 5:34 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
279,420 | $0 | 17,836 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
72,259 | $6.32 | 75,763 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-16 5:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
6,556 | $6.35 | 75,763 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 5:34 pm |
N/A 2024-09-15 |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
78,815 | $0 | 75,763 (Direct) |
View |
| 2022-07-29 Other |
2022-08-26 4:14 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
265 | $14.12 | 530 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:14 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
22,846 | $6.32 | 530 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:14 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
2,154 | $6.35 | 530 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:14 pm |
N/A 2024-12-18 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $0 | 530 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
14,000 | $8.93 | 32,000 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:05 pm |
N/A 2028-02-08 |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
24,000 | $0 | 32,000 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
10,000 | $9.63 | 32,000 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-27 6:42 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
31,602 | $6.38 | 17,659 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-27 6:42 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
31,602 | $0 | 17,659 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-08 5:51 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
15,109 | $6.38 | 17,659 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-08 5:51 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
15,109 | $0 | 17,659 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-05 4:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $7.2 | 17,836 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-05 4:09 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
62,292 | $0 | 17,836 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:12 pm |
N/A 2032-06-13 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
230,000 | $15.6 | 233,205 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:12 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
3,205 | $0 | 233,205 (Direct) |
View |
| 2022-04-01 Exercise(A) |
2022-04-13 4:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $7.2 | 20,964 (Direct) |
View |
| 2022-04-01 Exercise(A) |
2022-04-13 4:09 pm |
N/A 2025-06-30 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $0 | 20,964 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $10.9 | 17,836 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:05 pm |
N/A 2025-09-09 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
73,673 | $0 | 17,836 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:24 pm |
N/A 2032-03-01 |
Syndax Pharmaceuticals Inc | SNDX | Madigan Catherine Chief Medical Officer |
180,000 | $16.06 | 180,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:33 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
325,000 | $15.79 | 325,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:32 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
160,000 | $15.79 | 160,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:32 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
80,000 | $15.79 | 81,412 (Direct) |
View |
| 2022-01-31 Other |
2022-02-03 5:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
1,412 | $12.39 | 81,412 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:31 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer |
17,350 | $15.79 | 42,344 (Direct) |
View |
| 2022-01-31 Other |
2022-02-03 5:31 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer |
1,714 | $12.39 | 42,344 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:31 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
30,000 | $15.79 | 30,968 (Direct) |
View |
| 2022-01-31 Other |
2022-02-03 5:31 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
968 | $12.39 | 30,968 (Direct) |
View |